Articles From: NeuLion to Present at Canaccord Genuity 34th Annual Growth Conference to Neustar Named One of the Top Workplaces by The Washington Post


http://media.marketwire.com/attachments/201009/643413_newlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135532&ProfileId=051205&sourceType=1 PLAINVIEW, NY --
Sign-up for NeuLion to Present at Canaccord Genuity 34th Annual Growth Conference investment picks
2014/6/30
GERMANTOWN, Md.
Sign-up for Neuralstem Added To Russell 3000 Index investment picks
2014/9/5
Live Webcast on Wednesday, September 10, at 2:55 p.m. EST GERMANTOWN, Md.
Sign-up for Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference investment picks
2014/8/8
GERMANTOWN, Md.
Sign-up for Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update investment picks
Cognitive Deficit and Depression Symptoms Improve Significantly, Trial Data Shows GERMANTOWN, Md.
Sign-up for Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder investment picks
LAVAL, Quebec, June 20, 2014 (GLOBE NEWSWIRE) -- NeuroBioPharm Inc. ("NeuroBio" or the "Corporation") a Neptune Technologies & Bioressources Inc. subsidiary ("Neptune") (Nasdaq:NEPT) (TSX:NTB) announces that at its Annual General Meeting (the "Meeting"), held on June 19, 2014, the Corporation's shareholders voted in favour of all items put forth at the Meeting and outlined in the Corporation's management proxy circular dated May 22, 2014 (the "Circular") available on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml .
Sign-up for NeuroBioPharm Reports Results of Annual General Meeting investment picks
Earnings Release After Close of Market, Wednesday, August 6, 2014 Conference Call and Webcast Scheduled For Thursday, August 7, 2014 SAN DIEGO , July 29, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2014 financial results after the Nasdaq market closes on Wednesday, August 6, 2014 .
Sign-up for Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results investment picks
SUCCESSFUL END-OF-PHASE II MEETING FOR NBI-98854 IN TARDIVE DYSKINESIA TOURETTE SYNDROME IND FOR NBI-98854 TO BE FILED THIS MONTH SAN DIEGO , Aug.
Sign-up for Neurocrine Biosciences Reports Second Quarter 2014 Results investment picks
Live Audio Webcast will be on September 10, 2014 SAN DIEGO , Sept.
Sign-up for Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference investment picks
NeuroMetrix, Inc. (Nasdaq:NURO) (the "Company" or "NURO"), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today announced that it entered into a definitive securities purchase agreement with a single institutional investor providing for the issuance of $8,000,000 of shares of common stock and Series A-3 and Series A-4 convertible preferred stock (for a combined total of 3,921,569 shares of common stock, either outright or issuable upon conversion of the preferred stock) and five year warrants to purchase up to 3,921,569 shares of common stock at an exercise price of $2.04 per share.
Sign-up for NeuroMetrix Announces $8 Million Preferred Stock Placement investment picks
NeuroMetrix, Inc. (NASDAQ: NURO) reported today that it had reached the 10th anniversary of its initial listing on NASDAQ.
Sign-up for NeuroMetrix Marks 10th Year Anniversary of Listing on NASDAQ investment picks
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer.
Sign-up for NeuroMetrix Names Senior Executive to Lead Consumer Healthcare Initiative Frank McGillin - SVP and GM, Consumer investment picks
NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today reported the receipt of marketing certification from Technischer Überwachungs-Verein SÜD Japan Ltd.
Sign-up for NeuroMetrix Reports Japan Regulatory Approval for NC-stat DPNCheck investment picks
NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), today reported business highlights for the quarter ended June 30, 2014.
Sign-up for NeuroMetrix Reports Second Quarter 2014 Financial Results and Business Highlights investment picks
NEW YORK (MarketWatch) -- Shares of health-care microcap NeuroMetrix Inc (NURO) surged 30% in premarket trade Tuesday, after the U.S. Food and Drug Administration approved its wearable technology for the treatment of chronic pain for over-the-counter use.
Sign-up for NeuroMetrix shares surge 30% as FDA approves pain treatment for OTC use investment picks
NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today announced that Shai N.
Sign-up for NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference investment picks
NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today said it plans to issue its 2014 second quarter financial results before the opening of the market on July 24, 2014.
Sign-up for NeuroMetrix, Inc. Announces Date for 2014 Second Quarter Financial Results Conference Call investment picks
2014/6/19
Neurotrope creates Office of the Chairman with Messrs.
Sign-up for Neurotrope Appoints Charles S. Ramat and Paul Freiman as Co-Chairmen of the Board investment picks
- Neurotrope enters into world-wide, exclusive license agreement with Mount Sinai; Files related provisional patent for Bryostatin-1 - PLANTATION, Fla.
Sign-up for Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C investment picks
2014/9/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144351&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for NEUSTAR 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against NeuStar, Inc. - NSR investment picks
Neustar , Inc. (NYSE: NSR), a trusted, neutral provider of real-time information services and analytics, today announced a partnership with comScore, Inc. (NASDAQ: SCOR) that will give marketers a unified marketing solution incorporating validated Campaign Essentials™ (vCE®) ad validation metrics in its offering.
Sign-up for Neustar and comScore Partner to Improve Brands’ Digital Ad Delivery through Customized Integration of In-Target and Viewability Measurement investment picks
NeuStar Inc. (NSR), which provides technology and clearinghouse services to telecommunications providers and Internet service providers, is considering putting itself up for sale, Reuters reported Friday on its website, citing people familiar with the matter.
Sign-up for NeuStar Considering Possible Sale of Company -Reuters investment picks
Neustar, Inc. (NYSE: NSR), a trusted neutral provider of real-time information and analytics, today announced that the Washington Post has named it one of the 2014 Top Workplaces .
Sign-up for Neustar Named One of the Top Workplaces by The Washington Post investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: NeuLion to Present at Canaccord Genuity 34th Annual Growth Conference to Neustar Named One of the Top Workplaces by The Washington Post
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices